Healio

PrEP deemed cost-effective in the Netherlands

Please provide your email address to receive an email when new articles are posted on . Pre-exposure prophylaxis, or PrEP, is a cost-effective approach to reducing HIV among men who have sex with men ...
Managed Healthcare Executive

Medicaid expansion linked to rising PrEP use, improved HIV prevention

Long-term Medicaid expansion was linked to substantial growth in PrEP prescribing, with earlier expansion states seeing far ...
The American Journal of Managed Care

Short-Term PrEP May Be Effective Alternative Method of HIV Prevention Among MSM

Gay, bisexual, and other men who have sex with other men (MSM) during episodes of high-risk behavior could benefit from short-term use of preexposure prophylaxis (PrEP) to lessen their chances of ...
Medscape

PrEP Effective in High-risk Group in Three-City Project

A demonstration project in three major US cities has shown a very low incidence of HIV infection, despite a high incidence of other sexually transmitted infections (STIs), in high-risk patients given ...
Healio

PrEP not cost-effective for people who inject drugs

Please provide your email address to receive an email when new articles are posted on . Recent findings published in the Annals of Internal Medicine showed that use of pre-exposure prophylaxis among ...
The American Journal of Managed Care

Estimating the Cost-Effectiveness of PrEP Over 40 Years

Short-term investments pertaining to the distribution of PrEP are expected to result in long-term cost-savings and promote significant health benefits following its introduction in Germany, according ...
Newsweek

HIV Breakthrough as New Injection 89% More Effective Than PrEP

A brand new drug might be more effective at preventing HIV than current methods. Many people take daily oral antiretroviral medication—known as PrEP (pre-exposure prophylaxis)—to protect themselves ...
Medscape

PrEP Safer, More Effective Than Many Physicians Realize

At the height of the AIDS epidemic, it seemed almost unimaginable that within 3 decades there would not only be effective treatment for the disease but also effective prophylaxis. In July 2012, in ...
Science Daily

Study proves pre-exposure prophylaxis (PrEP) is effective at preventing HIV in high-risk gay men

The Lancet today publishes the results of the PROUD study, which shows giving daily HIV medication to gay men who are HIV negative yet at high risk of becoming HIV positive is highly effective at ...
PharmiWeb

ViiV Healthcare shows more than 99% effectiveness in real-world studies for Apretude (cabotegravir long-acting), the only approved long-acting HIV PrEP, in data presented at ...

London, [16 OCTOBER 2024] – ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced the presentation of new real-world ...
News Medical

Could neutralizing SARS-CoV-2 monoclonal antibodies pre-exposure prophylaxis be cost-effective in a population at risk for severe COVID-19?

A recent study published in JAMA Network Open evaluated the cost-effectiveness of monoclonal antibodies (mAbs) as pre-exposure prophylaxis (PrEP) for coronavirus disease 2019 (COVID-19). Study: Health ...